PEPTONIC medical AB (publ) (XSAT:PMED)
Sweden
· Delayed Price · Currency is SEK 0.0600
0.00 (0.00%)
At close: Jan 31, 2024
PEPTONIC medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 14.79 | 26.89 | 37.12 | 43.63 | 31.64 | Upgrade
|
| Revenue Growth (YoY) | -45.01% | -27.55% | -14.93% | 37.90% | 48.68% | Upgrade
|
| Cost of Revenue | 4.84 | 11.73 | 20.82 | 20.24 | 12.57 | Upgrade
|
| Gross Profit | 9.95 | 15.16 | 16.3 | 23.4 | 19.07 | Upgrade
|
| Selling, General & Admin | 35.3 | 56.72 | 52.28 | 56.11 | 65.12 | Upgrade
|
| Other Operating Expenses | -11.65 | -7.64 | -1.06 | -2.6 | 0.61 | Upgrade
|
| Operating Expenses | 29.4 | 73.81 | 57.48 | 57 | 92.79 | Upgrade
|
| Operating Income | -19.45 | -58.65 | -41.19 | -33.61 | -73.72 | Upgrade
|
| Interest Expense | -3.09 | -1.41 | -2.32 | -5.56 | -0.07 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.03 | 0.92 | 2.31 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | 0 | - | -0 | Upgrade
|
| Pretax Income | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 | Upgrade
|
| Net Income | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 | Upgrade
|
| Net Income to Common | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 | Upgrade
|
| Shares Outstanding (Basic) | 8,425 | 3,600 | 1,535 | 243 | 192 | Upgrade
|
| Shares Outstanding (Diluted) | 8,425 | 3,600 | 1,535 | 243 | 192 | Upgrade
|
| Shares Change (YoY) | 134.00% | 134.57% | 532.29% | 26.67% | 17.63% | Upgrade
|
| EPS (Basic) | -0.00 | -0.02 | -0.03 | -0.15 | -0.38 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.02 | -0.03 | -0.15 | -0.38 | Upgrade
|
| Free Cash Flow | - | -37.56 | -34.45 | -40.22 | -43.36 | Upgrade
|
| Free Cash Flow Per Share | - | -0.01 | -0.02 | -0.17 | -0.23 | Upgrade
|
| Gross Margin | 67.31% | 56.38% | 43.90% | 53.62% | 60.27% | Upgrade
|
| Operating Margin | -131.52% | -218.10% | -110.96% | -77.02% | -232.97% | Upgrade
|
| Profit Margin | -152.12% | -223.23% | -114.74% | -84.47% | -232.87% | Upgrade
|
| Free Cash Flow Margin | - | -139.66% | -92.82% | -92.17% | -137.04% | Upgrade
|
| EBITDA | -17.52 | -56.4 | -39.62 | -32.91 | -49.61 | Upgrade
|
| EBITDA Margin | -118.46% | -209.72% | -106.75% | -75.41% | -156.78% | Upgrade
|
| D&A For EBITDA | 1.93 | 2.25 | 1.56 | 0.7 | 24.11 | Upgrade
|
| EBIT | -19.45 | -58.65 | -41.19 | -33.61 | -73.72 | Upgrade
|
| EBIT Margin | -131.52% | -218.10% | -110.96% | -77.02% | -232.97% | Upgrade
|
| Revenue as Reported | 26.75 | 27.62 | 38.27 | 46.4 | 32.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.